Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy
The present study evaluated the efficacy and safety of human embryonic stem cell (hESC) therapy in patients with CP.
The present study evaluated the efficacy and safety of human embryonic stem cell (hESC) therapy in patients with CP.
Brain SPECT is an extremely useful tool in monitoring the treatment response to stem cell therapy in patients of cerebral palsy.
Duchenne muscular dystrophy (DMD), an X-linked disorder, occurs due to mutation, deletion or duplication of the DMD gene which encodes the protein dystropin.
Human embryonic stem cells are pluri – potent cell lines usually derived from human
Human embryonic stem cells (hESCs) have a role in treating neurological disorders. The
“Human embryonic stem cells (hESCs) are pluripotent cells that have the potential to
“Cerebral palsy (CP) is caused by abnormalities in the developing brain leading to an
“Use of human embryonic stem cells (hESCs) has been explored for
Spinal cord injury (SCI) is a devastating disease which impacts the patient physically, psychologically and financially.
Age-related macular degeneration (AMD), a progressive neurodegenerative condition, primarily affects the retinal pigmented epithelium resulting in degeneration of photoreceptors.
Thanks for contacting ReoStem! We have received your response and we will get back to you shortly.